The Histocompatibility-2 (H-2) gene complex contains the major histocompatibility system of the mouse (1, 2) . In addition to genes determining transplantation antigens, the genetic control of several physiological processes, especially immune responses, has been linked with this complex (2, 3). H-2 linked genes determining the level of secondary immune response to synthetic polypeptides, and the degree of response to low doses of native antigen and to alloantigens have been described. Genetically controlled response to infection with several leukemia viruses is also linked to the H-2 region (4) (5) (6) (7) (8) . The linked traits include susceptibility to primary infection and severity of an established infection; they may not be due to immune response against the viruses. Still more general physiological traits appear to be affected by H-2 region genes. Steroid-sensitive organ weights and the level of plasma complement and steroids all appear to depend to some extent on H-2 genotype, and characteristic values for these systems segregate with H-2 in F2 and backcross animals (9) (10) (11) .
Some progress has been made in mapping genes responsible for H-2-associated physiological effects; at least three of them lie within the H-2 complex. Studies with recombinant H-2 mice have shown that the Ir-i gene controlling response to synthetic antigens and the genes controlling the immune response to allogeneic myeloma proteins, Ir-IgA and Ir-IgG, can be separately localized within H-2, between H-2K and Ss-Slp regions (12, 13) . The region carrying these three Ir genes most probably contains an even larger number of distinct Ir genes (13) . The factor affecting resistance to Gross virus leukemogenesis has been located in the K-end of the H-2 complex, but it has not been further separated from known genes of the region.
The immune response genes have been discussed in terms of a system of many linked Ir genes, the products of which serve as antigen receptors on T cells (2 (14) , it appears that a common property of H-2 complex genes is their effect on the cell plasma membrane. All of the antigens determined by the complex, including Ss protein, appear in the surface membranes of some cells (15) , while all of the other genes of the complex appear to affect receptor-ligand associations at the cell surface (although in the case of Hom-1, the gene affecting plasma steroid levels, the effect may be one step removed from the phenotype measured).
We might expect that still other processes involving interactions at the cell surface are affected by H-2 genotype, either because many genes affecting membrane phenotypes lie within the complex, or because a relatively small number of genes exert a wide range of effects on membrane function. The present paper demonstrates an association of H-2 genotype with levels of liver cyclic AMP, a mediator of the action of many polypeptide hormones (16, 17 (24) .
Extraction of Liver cAMP. Animals were killed by cervical dislocation. Their livers were excised in less than 30 sec, and frozen in liquid nitrogen; livers were stored in a -70°f reezer for 1-4 days before processing. Each frozen liver was weighed, taken to a cold room, and homogenized with a Waring Blendor in 9 ml of cold trichloroacetic acid or perchloric acid. After removal of precipitated protein by centrifugation trichloroacetic acid was extracted with ether, while perchloric acid was neutralized with KOH. The potassium perchlorate that remained soluble after centrifugation in the second procedure did not interfere with further steps in the extraction.
Liver extracts were next taken to dryness by blowing air over them while they were immersed in a 450 water bath.
After drying, the extracts were reconstituted in 5 ml of distilled water. To each were added 0.5 ml of 0.3 N ZnSO4 and 0.5 ml of 0.3 N Ba(OH)2. The mixture was chilled in ice for 15 min,-after which the precipitate was centrifuged down (1000 X g for 10 min) and discarded. This step was found, as has been reported, to remove interfering nucleosides and nucleotides (25) . A tracer amount of [3H]cAMP was added during homogenization to allow computation of recoveries after extraction and purification. The radiochemical purity of this marker was estimated before and after the procedure by electrophoresis in 1% sodium borate buffer, followed by chromatography in 95% ethanol-ammonium acetate (70:30) (26). Recovery of cAMP estimated by counting a portion of the extract averaged 60%, with values for individual extractions forming a normal distribution around this mean.
After the above steps, extracts contained the equivalent of 200-400 mg of tissue wet weight per ml. They were then assayed at five or more dilutions using a minimum of two samples after each dilution. To measure variation in binding during the assay, dilutions of a standard solution of cAMP were intercalated every 50 samples (five animals) and assayed for cAMP content. Large numbers of extracts were assayed once again, several months later, to ensure reproduc- (25) . Under certain conditions, it has been reported that treatment with Ba(OH)2-ZnSO4 converts ATP present in extracts to cAMP (27, 28) . This nonenzymatic conversion occurs much faster at room temperature than at 0-40. For this reason, treatment of extracts was conducted in ice, following, never preceding, the evaporation step described above. No conversion of ATP to cAMP was found using the extraction procedure described above. In one experiment, a 1000-fold excess of [14C]ATP was added together with the [3H]cAMP tracer to each of 10 liver homogenates. cAMP was separated from half of each extract by absorption to and elution from AG-1-X2 ion exchange resin (27) , and then dried and treated with Ba(OH)2-ZnSO4 while the other half was treated only with Ba(OH)2-ZnSO4. No be determined for AG-I-X2-treated and -untreated fractions. Although 5% of the added ATP remained in samples not eluted from a column, this in turn could be absorbed to a fresh AG-1-X2 column.
Statistical Analysis. Fig. 1 shows an assay of standard cAMP and of two liver extracts. In this analytical dilution assay (29) displacement of bound [3H]cAMP by unlabeled cAMP is compared for a standard solution of the nucleotides and for the extracts. Though not shown in the figure, the assay was valid over the range 2.5 nM to 0.1 ,uM cAMP.
Data obtained from measurements of tissue extracts at several dilutions were fitted to a straight line by a method of least squares. The line obtained was tested for lack of linearity by a goodness of fit test (30) . After fitting, coviriance analysis (31) was used to test the criterion that no constituent of the sample other than its endogenous cAMP content had an effect on the measurements. When this criterion was met, as is required for analytical dilution assays, the sample and standard lines obtained were parallel to each other. In addition, this analysis was used to determine whether all standards in one assay were equal. If the conditions of parallelism and constant standards were met, then the analysis further indicated differences in liver cAMP content among strains compared. For convenience, data were normalized to liver wet weight, since liver protein/total wet weight did not differ among the four C57BL/10-based congenic strains.
The above analysis tested whether differences existed among a group of strains, but did not indicate which strains differed from each other. For The data points for animals with various H-2 regions on the C57BL/10 background fell on four distinct curves, three of which are shown in Fig. 2 Fig. 4 ]. Finally, H-2d/H-2 k heterozygotes, whether F1 or F2 animals, are anomalous. These offspring of two cAMP low strains have hepatic levels of cAMP as high as those of the H-2a strains A/J and B1O.A. DISCUSSION The use of congenic resistant mouse strains allowed us to state with a fair degree of certainty that the measured differences in basal level of cAMP per mg wet weight among strains were associated with the H-2 chromosome complex. Furthermore, the associations were not masked by the genetic background, since nearly equal values for liver cAMP were determined for animals with H-2 regions on three different genetic backgrounds, C57BL/10, C3H, and A.
The reason for increase in cAMP levels with age is not as apparent, though some precedent for this observation is found in observations on changes in enzyme levels with age in rodent liver (33) . These changes and the one that we ob- (34) .
Tests with F2 animals from crosses of (BiO X B1O.BR), (B1O.D2 X B1O.BR), and (B1O.A X B1O.BR) point to a dominant genetic factor or factors affecting cAMP levels in liver identical or closely associated with the H-2 complex. They also fail to show segregation of any other genetic locus that may have been included when our congenic resistant strains were created. Finally, the crosses rule out environmental effects, since they were all done in a single breeding room.
The fact that B1O.A mice, which are suspected (H-2d/H2k) recombinants, had higher liver cAMP levels than either of the haplotypes from which the recombinant arose, indicates that at least two genes are needed to produce higher levels of liver cAMP. This hypothesis is strongly supported by the finding that the F1 hybrid between strains with low levels of liver cAMP, B1O.D2 and B1O.BR, had liver cAMP levels as high as B1O.A or A/J animals. Since the suspected crossover for B1O.A mice occurred between Ir-IgG and SsSip (35) , it further appears that both ends of the H-2 region are involved in controlling cAMP levels in liver. Variation in cAMP levels in liver is thus another quantitative trait apparently linked to the major histocompatibility complex of the mouse. To our knowledge, it is one of the few traits so linked that is clearly involved in more processes than those of the immune system. Liver, though it contains some lymphocytes, is not primarily an organ of immune response. It is, however, a tissue in which numerous hormones converge on a variety of cells, modifying their metabolism via the effector cyclic AMP (36) . Ivanyi suggested that H-2 region genes had more general effects than on the immune response alone. Both this work and our own raise two questions about the 1H-2-linked genetic control of cell physiology. First, what is the level or point of control and second, what are the implications of this control in whole animals? The answers to the second question are liable to be long in coming, but three mechanisms for genetic control of cAMP levels, which represent cell responses to a wide variety of hormones, come immediately to mind. Two of these would involve differences in activity of adenylate cyclase, the enzyme synthesizing cAMP from ATP, or in 3': 5'-cAMP phosphodiesterase, the cAMP degrading enzyme. Both of these enzymes, although internal to the cell surface, are membrane-associated (37, 39) . Differences in their activity would suggest that genes acting on the cytoplasmic side of the cell surface cluster in the H-2 complex. A third possibility is that the differences in levels of cAMP observed are a direct consequence of the effect of H-2-linked genes on the, binding of hormones and other molecules to the cell surface. H-2-linked genetic control of surface interactions could be exercised in two ways. First, genes determining variant configurations of polypeptide hormone receptors may be present in the H-2 complex. We would expect that there are at least five of these genes in the region, corresponding to the number of hormones shown to stimulate adenylate cyclase independently (see ref. 38) . A second, somewhat less straightforward possibility is that antigenic products of the 1-2 complex modify the interaction of hormones and other ligands with their specific receptors. H-2 antigens are mobile in the plane of the plasma membrane (40) , and probably outnumber hormone receptors in liver and lymphoid cells; their human homologue, HL-A, is present in approximately 50-fold excess over insulin receptor on lymphoid cells (41) (42) (43) . A receptor surrounded by H-2 antigens might, because of weak interaction with them, have an altered affinity for hormone.
All of the control points suggested here are at the level of *the liver cell's response to hormones. Clearly further points of control might be found, ranging from blood levels of hormones stimulating the liver cells, to the utilization of cAMP by protein kinases, or to its export into the blood. Further experiment on liver cell and homogenate preparations will be required to resolve the possibilities listed here.
